Polymorphic CAG and GGC Repeat Lengths in the Androgen Receptor Gene and Prostate Cancer Risk: Analysis of a Brazilian Population

REFERENCES

• Grönberg H. Prostate cancer epidemiology. The Lancet 2003; 361: 859–864
   PubMed Web of Science ®Google Scholar
• Nelson W. G., De Marzom A. M., Isaacs W. B. Prostate cancer. New England Journal of Medicine 2003; 349: 366–381
   PubMed Web of Science ®Google Scholar
• Whatare the key statistics about prostate cancer?. American Cancer Society, http://www.cancer.org Reference Information. Available at Accessed 03/03/2006.
   Google Scholar
• Câncerde próstata: consenso. Instituto Nacional do Câncer. Ministério da Saúde, Brasil 2002
   Google Scholar
• INCA (Instituto Nacional do Câncer). Ministério da Saúde, Brasil. Estimativa de incidência e mortalidade por câncer no Brasil para 2005, http://www.inca.gov.br. Available at Accessed 11/21/2005.
   Google Scholar
• Carter H. B., Partin A. W. Diagnosis and staging of prostate cancer. Walsh: Campbell's Urology, 8th edition. WB Saunders. 2002; 3055–3064
   Google Scholar
• Balic I., Graham S. T., Troyer D. A., Higgins B. A., Pollock B. H., Johnson-Pais T. L., Thompson I. M., Leach R. J. Androgen receptor length polymorphism associated with prostate cancer risk in hispanic men. The Journal of Urology 2002; 168: 2245–2248
   PubMed Web of Science ®Google Scholar
• Coughlin S. S., Hall H. L. A review of genetic polymorphisms and prostate cancer risk. Annals of Epidemiology 2002; 12: 182–196
   PubMed Web of Science ®Google Scholar
• Nelson K. A., Witte J. S. Androgen receptor CAG repeats and prostate cancer. American Journal of Epidemiology 2002; 155: 883–890
   PubMed Web of Science ®Google Scholar
• Linja M. J., Visakorpi T. Alterations of androgen receptor in prostate cancer. Journal of Steroid Biochemistry & Molecular Biology 2004; 92: 255–264
   PubMed Web of Science ®Google Scholar
• Tsujimoto Y., Takakuwa T., Takayama H., Nishimura K., Okuyama A., Aozasa K., Nomomura N. In Situ Shortening of CAG repeat length within the androgen receptor gene in prostatic cancer and its possible precursors. The Prostate 2004; 58: 283–290
   PubMed Web of Science ®Google Scholar
• Platz E. A., Leitzmann M. F., Rifai N., Kantoff P. W., Chen Y. C., Stampfer M. J., Willet W. C., Giovanucci E. Sex Steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era. Cancer Epidemiology, Biomarkers & Prevention 2005; 14(5)1262–1269
   PubMed Web of Science ®Google Scholar
• Kantoff P., Giovanucci E., Brown M. The androgen receptor CAG repeat polymorphism and its relationship to prostate cancer. Biochimica et Biophysica Acta 1998; 1378: C1–C5
   PubMed Web of Science ®Google Scholar
• Mahtre A. N., Trifiro M. A., Kaufman M., Kazemi-Esfarjani P., Figlewicz D., Rouleau G., Pinsky L. Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nature Genetics 1993; 5(2)184–188
   PubMed Web of Science ®Google Scholar
• Sartor O., Zheng Q., Eastham JÁ. Androgen receptor gene CAG repeat length varies in a race-specific fashion in men without prostate cancer. Urology 1999; 53(2)378–380
   PubMed Web of Science ®Google Scholar
• Giovanucci E., Stampfer M. J., Krithivas K., Brown M., Brufsky A., Talcott J., Hennekens C. H., Kantoff P. W., The C AG. repeat within the androgen receptor gene and its relationship to prostate cancer. Proceedings of the National Academy of Sciences 1997; 94: 3320–3323
   PubMed Web of Science ®Google Scholar
• Ingles S. A., Ross R. K., Yu M. C., Irvine R. A., La Pera G., Haile R. W., Coetzee G. A. Association of prostate cancer risk with genetic polymorphism in vitamin D receptor and androgen receptor. Journal of National Cancer Institute 1997; 89(2)166–170
   PubMed Web of Science ®Google Scholar
• Correa-Cerro L., Wohr G., Haussler J., Berthon P., Drelon E., Mangin P., Fournier P., Cussenot O., Kraus P., Just W., et al. (CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German Population. European Journal of Human Genetics 1999; 7(3)357–362
   PubMed Web of Science ®Google Scholar
• Bratt O., Borg A., Kristoffersson U., Lundgren R., Zhang Q. X., Olsson H. CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk. British Journal of Cancer 1999; 81(4)672–676
   PubMed Web of Science ®Google Scholar
• Santos M. L., Sarkis A. S., Nishimoto I. N., Nagai M. A. Androgen receptor CAG repeat polymorphism in prostate cancer from a Brazilian population. Cancer Detection and Prevention 2003; 27: 321–326
   PubMedGoogle Scholar
• Hsing A. W., Gao Y. T., Wu G., Wang X., Deng J., Chen Y. L., et al. Polymorphic CAG and GGN Repeat Lengths in the Androgen Receptor Gene and Prostate Cancer Risk: A population-based Case-Control Study in China. Cancer Research 2000; 60: 5111–5116
   PubMed Web of Science ®Google Scholar
• Stanford J. L., Just J. J., Gibbs M., Wicklund K. G., Neal C. L., Blumenstein B. A., Ostrander E. A. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Research 1997; 57(6)1194–1198
   PubMed Web of Science ®Google Scholar
• Hakimi J. M., Schoenberg M. P., Rondinelli R. H., Piantadosi S., Barrack E. R. Androgen Receptor Variants with Short Glutamine or Glycine repeats may identify unique subpopulations of men with prostate cancer. Clinical Cancer Research 1997; 3(9)1599–608
   PubMed Web of Science ®Google Scholar
• Kittles R. A., Young D., Weinrich S., Hudson J., Argyropoulos G., Ukoli F. Extent of linkage Disequilibrium Between the Androgen Receptor Gene CAG and GGC Repeats in Human Populations: Implications for Prostate Cancer Risk. Human Genetics 2001; 109: 253–261
   PubMed Web of Science ®Google Scholar
• Zeegers M. P., Kiemeney L. A.L. M., Nieder A. M., Ostrer H. How strong is the association between CAG e GGN repeat length polimorphisms in the androgen receptor gene and prostate cancer risk?. Cancer Epidemiology, Biomarkers & Prevention 2004; 13(11)1765–1771
   PubMed Web of Science ®Google Scholar
• Freedman M. L., Pearce C. L., Penney K. L., Hirschhorn J. N., Kolonel L. N., Henderson B. E., Altshuler D. Systematic evaluation of genetic variation at the androgen receptor locus and risk of prostate cancer in a multiethnic cohort study. American Journal of Human Genetics 2005; 76: 82–90
   PubMed Web of Science ®Google Scholar
• Parra F. C., Amado R. C., Lambertucci J. R., Rocha J., Antunes C. M., Pena S. D.J. Color and genomic ancestry in brazilians. Proccedings of the National Academy of Sciences of the United States of America 2003; 100(1)177–182
   PubMed Web of Science ®Google Scholar
• Marrero A. R., Leite F. P.N., Carvalho B. A., Peres L. M., Kommers T. C., Cruz I. M., Salzano F. M., Ruiz-Linares A., Da Silva Júnior W. A., Bortolini M. C. Heterogeneity of the genome ancestry of individuals classified as White in the state of Rio Grande do Sul, Brazil. American Journal of Human Biology 2005; 17(4)496–506
   PubMed Web of Science ®Google Scholar
• Chang B. L., Zheng S. L., Hawkins G. A., Isaacs S. D., Wiley K. E., Turner A., et al. Polymorphic GGC Repeats in the Androgen Receptor Gene are Associated with Hereditary and Sporadic Prostate Cancer Risk. Human Gnetics 2002; 110: 122–12
   PubMed Web of Science ®Google Scholar
• Chen C., Lambarzi N., Weiss N. S., Etzioni R., Dightman D. A., Barnett M., Di Tommaso D., Goodman G. Androgen receptor polymorphism and the incidence of prostate cancer. Cancer Epidemiology, Biomarkers & Prevention 2002; 11: 1033–1040
   PubMed Web of Science ®Google Scholar
• Ferlin A., Bartolini L., Rizzo G., Roverato A., Garolla A., Foresta C. Androgen receptor gene CAG and GGC repeat lengths in idiopathic male infertility. Molecular Human Reproduction 2004; 10(6)417–421
   PubMed Web of Science ®Google Scholar